Cargando…
Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine –possible therapeutic implication
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19. Until now, diverse drugs have been used for the treatment of COVID-19. These drugs are associated with severe side effects, e.g. induction of erythrocyte death, named eryptosis. This massively affects the oxygen (O(2))...
Autores principales: | Ghashghaeinia, Mehrdad, Dreischer, Peter, Wieder, Thomas, Köberle, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781621/ https://www.ncbi.nlm.nih.gov/pubmed/33305655 http://dx.doi.org/10.1080/15384101.2020.1859197 |
Ejemplares similares
-
The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020) -
Association between nuclear factor of kappa B (NFκB) deficiency and induction of eryptosis in mouse erythrocytes
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2020) -
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11–7082, parthenolide and dimethyl fumarate
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2016) -
Desipramine induces eryptosis in human erythrocytes, an effect blunted by nitric oxide donor sodium nitroprusside and N-acetyl-L-cysteine but enhanced by Calcium depletion
por: Pan, Xia, et al.
Publicado: (2023) -
Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes
por: Ghashghaeinia, Mehrdad, et al.
Publicado: (2019)